REQUEST A DEMO
Total
USD $0.00
Search more companies

Idaman Pharma Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Idaman Pharma Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Idaman Pharma Sdn. Bhd. is a healthcare service company that targets the professional healthcare industry and offers various products, solutions, and services. It operates in the healthcare sector.

Headquarters
No. 15 & 17 Jalan Wangsa Delima 1A, Seksyen 5 Pusat Bandar Wangsa Maju
Kuala Lumpur; Federal Territories; Postal Code: 53300

Contact Details: Purchase the Idaman Pharma Sdn. Bhd. report to view the information.

Website: http://www.idamanpharma.com

Basic Information
Total Employees:
Purchase the Idaman Pharma Sdn. Bhd. report to view the information.
Outstanding Shares:
Purchase the Idaman Pharma Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Idaman Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Idaman Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
August 03, 2001
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
30%
Purchase this report to view the information.
30%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Subsidiaries
Seri Idamanbina Sdn. Bhd.
80%
Alif Global Intertrade Sdn. Bhd.
60%
Company Performance
Financial values in the chart are available after Idaman Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-2.85%
Total operating revenue
-2.85%
Operating profit (EBIT)
37.44%
Net Profit (Loss) for the Period
46.15%
Total assets
54.78%
Total equity
19.17%
Operating Profit Margin (ROS)
2.23%
Net Profit Margin
1.68%
Return on Equity (ROE)
5.08%
Debt to Equity Ratio
197.2%
Quick Ratio
0.16%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?